Medicare AWP Rule: BIO Urges Careful Definition Of “Average Sales Price”

CMS should follow the House Medicare bill's definition of "average sales price" if it chooses a competitive acquisition model to reform the AWP payment system, the Biotechnology Industry Organization suggests